Читать книгу Anti-Aging Therapeutics Volume XVII - A4M American Academy - Страница 13

Patient has pacemaker after open-heart surgery at age 2 performed at Children’s Hospital in Boston (Corrected L-transposition, closure of VSD). In March of 2002, patient was diagnosed with a thrombus measuring 10mm x 0.9mm located on heart valve. He had been on an average of 2 mg Coumadin for 2-months, but had not yet reached a therapeutic level, which was set between 2-3 (INR). His blood results came back as 1.75, 1.8, 3.8 and 4.2.

Head cardiologist David Fulton, M.D. an assistant professor at Harvard Medical School, was considering surgically removing the thrombus due to the non-responsiveness of the patient to Coumadin. To potentially avoid surgery, the therapeutic approach of biofeedback and focused field stimulation was added to the treatment of the anti-coagulant.

The frequencies emitted from the technology were tested at Children’s Hospital at Westchester Medical Center, NY, for possible interference with pacemaker. There were no fluctuations of the pacemaker or in the heart as seen on the echocardiogram as well as pacemaker testing device from Medtronic. Three therapeutic sessions were administered within 4-days; scanning and applying patient specific frequencies. The patient’s reaction areas were noted in patient data sheet and were stimulated with the patient-specific frequencies. Another INR blood test was taken several days later and for the first time in 3-months, RL reached a therapeutic level of 2.7.

Two additional biofeedback and focused field stimulation therapies were administered over the following 5-days. After only 5 treatments over 2-weeks, the patient was examined with an echocardiogram at Westchester Medical Center, NY, which showed a reduction of the thrombus to 0.9mm x 0.6mm. Patient continued the sessions weekly. Three weeks later another echocardiogram showed that the thrombosis had further reduced to 0.6mm x 0.5mm.

Patient received sessions every 2-weeks with individual frequencies and pre-set programs. Just 3-months later, patient’s thrombosis was barely visible on the echocardiogram and patient was taken off the Coumadin medication. Patient successfully avoided having to go through open-heart surgery by adding biofeedback & focused field stimulation therapy to the existing treatment protocol. According to pediatric cardiologist Aaron Levine, M.D. Children’s Hospital at Westchester Medical Center, who stated in his letter dated October 2003 to the patient’s pediatrician:

“The thrombus as described in previous letters by Dr. Woolf is not clearly seen at this examination”.

The patient remains in good health, without any medication and quarterly maintenance treatment. He is now 17-years-old (July 2014) and recent examination at the University Clinic in Freiburg, Germany, revealed a healthy heart without any signs of a thrombus.